2003年,在严重急性呼吸道综合征流行期间,死亡人数不到800人。
结论在近期有过一次急性冠脉综合征的患者中,利伐沙班降低了包括心血管原因所致死亡、心肌梗死或卒中的复合终点的发生危险。
CONCLUSIONS in patients with a recent acute coronary syndrome, rivaroxaban reduced the risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke.
昨日一个热点会议发布,新的研究数据表明与药物洗脱支架(DES)有关的急性冠状动脉综合征死亡率不断增加。
NEW DATA showing increased mortality rates associated with drug eluting stents (DES) in acute coronary syndromes were presented in a Hot Line Session yesterday.
应用推荐